SEC 13F Intelligence

Managers / Q3 2022

MORGAN JESS S & CO INC

CIK 0001133335 · C/O JESS S MORGAN & CO INC, 5900 WILSHIRE BLVD STE 2300, LOS ANGELES, CA, 90036 · 3236342400

Reported Value
$115M
Q3 2022
Positions
36
Filings on Record
12
2019–present window
Filed
Oct 21, 2022
original filing

Summary

Morgan Jess S & Co Inc reported $115M in U.S.-listed holdings across 36 positions for Q3 2022.

Its largest position, Proshares Tr, represents 10.5% of the portfolio.

Compared with Q2 2022, the fund opened 2 new positions and exited 3.

Portfolio Metrics

Turnover
+6.1%
vs prior filed quarter
Top-10 Concentration
+47.0%
share of reported value
Largest Position
+10.5%
Proshares Tr
New / Exited
2 / 3
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q3 ’21: $152MQ3 ’21Q4 ’21: $163MQ4 ’21Q1 ’22: $137MQ1 ’22Q2 ’22: $96MQ2 ’22Q3 ’22: $115MQ3 ’22filingsflow.com

Portfolio Composition

By security type
ETP: 42.3%Common Stock: 38.4%Other: 18.3%Closed-End Fund: 1.0%
  • ETP · 42.3% · $49M
  • Common Stock · 38.4% · $44M
  • Other · 18.3% · $21M
  • Closed-End Fund · 1.0% · $1M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PROSHARES TRNEW+539.3K539.3K+$12M$12M
PROSHARES TRNEW+84.9K84.9K+$5M$5M
SELECT SECTOR SPDR TRADDED+42.2K55.8K+$3M$4M
ADBEADOBE SYSTEMS INCORPORATEDSOLD OUT−8.0K0−$3M$0
INTCINTEL CORPSOLD OUT−6.0K0−$224,000$0
LCTXLINEAGE CELL THERAPEUTICS INSOLD OUT−20.0K0−$32,000$0
CKPTUSDCHECKPOINT THERAPEUTICS INCADDED+757.4K1.89M+$799,000$2M
VANGUARD INDEX FDSADDED+1.9K5.8K+$295,000$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2022

29 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1PROSHARES TRULTRAPRO SHORT S · ULTRAPRO SHT QQQ15.05%$17M624.2K
2ISHARES TRUS INDUSTRIALS · US OIL GS EX ETF · ISHARES SEMICDTR · RUSSELL 3000 ETF · EXPANDED TECH11.00%$13M102.5K
3SELECT SECTOR SPDR TRSBI CONS STPLS · TECHNOLOGY · SBI HEALTHCARE6.07%$7M83.0K
4NDQINVESCO QQQ TRhistory →UNIT SER 14.75%$5M20.4K
5DBCINVESCO DB COMMDY INDX TRCKhistory →UNIT4.27%$5M205.4K
6UNHUNITEDHEALTH GROUP INChistory →COM4.14%$5M9.4K
7FIRST TR EXCHANGE TRAD FD VIFST TR GLB FD3.99%$5M180.9K
8AAPLAPPLE INChistory →COM3.96%$5M33.0K
9PEPPEPSICO INChistory →COM3.75%$4M26.4K
10JNJJOHNSON & JOHNSONhistory →COM3.60%$4M25.3K
11SPDR SER TRS&P BIOTECH3.49%$4M50.5K
12NOVOCURE LTDORD SHS3.25%$4M49.1K
13INTUINTUIThistory →COM3.20%$4M9.5K
14AVGOBROADCOM INChistory →COM3.19%$4M8.3K
15AXSMAXSOME THERAPEUTICS INChistory →COM3.06%$4M78.9K
16TMOTHERMO FISHER SCIENTIFIC INChistory →COM3.02%$3M6.8K
17VANGUARD WORLD FDSCONSUM DIS ETF2.93%$3M14.3K
18HONGBPHONEYWELL INTL INChistory →COM2.83%$3M19.5K
19INVESCO EXCHANGE TRADED FD TAEROSPACE DEFN2.47%$3M44.0K
20AGENEURAGENUS INChistory →COM NEW2.32%$3M1.30M
21FIRST TR EXCHANGE-TRADED FDDJ INTERNT IDX2.24%$3M20.4K
22ORMPORAMED PHARMACEUTICALS INChistory →COM NEW2.07%$2M366.4K
23CKPTUSDCHECKPOINT THERAPEUTICS INChistory →COM1.71%$2M1.89M
24QQQXNUVEEN NASDAQ 100 DYNAMIC OVCOM SHS0.95%$1M53.4K
25VANGUARD INDEX FDSTOTAL STK MKT0.91%$1M5.8K
26MSFTMICROSOFT CORPCOM0.65%$748,0003.2K
27NVDANVIDIA CORPORATIONCOM0.65%$744,0006.1K
28CLNNEURCLENE INCCOMMON STOCK0.27%$314,000112.0K
29DIREXION SHS ETF TRSP BIOTCH BL NEW0.17%$200,00028.5K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2022$115M36Oct 21, 202213F-HRchanges · EDGAR ↗
Q2 2022$96M37Jul 18, 202213F-HRchanges · EDGAR ↗
Q1 2022$137M43May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$163M46Jan 27, 202213F-HRchanges · EDGAR ↗
Q3 2021$152M40Nov 30, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.